glp-1 clinical studies Orforglipron, an Oral Small-Molecule Receptor Agonist for Obesity Treatment GLP-1a: Going beyond Traditional Use
Description
Introduction and Background GLP-1 receptor agonists have revolutionized diabetes and obesity care with dramatic efficacy
When is it time to ask for help
Designed to help regulate blood sugar levels, Ozempic has also gained attention for its ability to aid in weight loss, which has led to a surge in off-label use
Additionally, the FDA's adverse event reporting system received 489 reports of patients experiencing mental health issues, including depression and anxiety, while on semaglutide (Ozempic's active ingredient)
